Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 46% ± 15% | |
lung | 17 studies | 34% ± 11% | |
intestine | 11 studies | 27% ± 12% | |
kidney | 7 studies | 35% ± 12% | |
brain | 6 studies | 23% ± 6% | |
bone marrow | 5 studies | 31% ± 14% | |
liver | 5 studies | 38% ± 24% | |
lymph node | 5 studies | 41% ± 7% | |
pancreas | 3 studies | 29% ± 10% | |
placenta | 3 studies | 47% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 3408.20 | 328 / 328 | 100% | 117.21 | 178 / 178 |
esophagus | 100% | 5186.17 | 1444 / 1445 | 100% | 92.59 | 183 / 183 |
thymus | 100% | 5752.28 | 653 / 653 | 100% | 135.67 | 604 / 605 |
skin | 100% | 6241.65 | 1809 / 1809 | 100% | 136.90 | 471 / 472 |
kidney | 100% | 6112.37 | 89 / 89 | 100% | 96.65 | 898 / 901 |
intestine | 100% | 5178.39 | 966 / 966 | 100% | 152.20 | 525 / 527 |
prostate | 100% | 4798.09 | 245 / 245 | 100% | 132.90 | 500 / 502 |
liver | 100% | 3739.98 | 226 / 226 | 100% | 85.55 | 404 / 406 |
lung | 100% | 4969.80 | 578 / 578 | 99% | 136.76 | 1149 / 1155 |
breast | 100% | 3907.51 | 459 / 459 | 99% | 137.80 | 1110 / 1118 |
brain | 99% | 3041.54 | 2622 / 2642 | 100% | 77.53 | 704 / 705 |
bladder | 100% | 3613.29 | 21 / 21 | 99% | 165.01 | 498 / 504 |
stomach | 100% | 4570.14 | 358 / 359 | 99% | 132.11 | 283 / 286 |
uterus | 99% | 2755.25 | 168 / 170 | 100% | 147.08 | 458 / 459 |
adrenal gland | 100% | 5663.90 | 258 / 258 | 97% | 79.39 | 222 / 230 |
ovary | 95% | 1927.57 | 171 / 180 | 100% | 165.24 | 430 / 430 |
adipose | 100% | 3848.85 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 112.12 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 266.48 | 29 / 29 |
spleen | 100% | 8417.51 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 160.35 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 138.77 | 1 / 1 |
muscle | 100% | 4281.14 | 802 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 9288.03 | 922 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2671.34 | 1320 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 3644.40 | 850 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030324 | Biological process | lung development |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0005979 | Biological process | regulation of glycogen biosynthetic process |
GO_0048754 | Biological process | branching morphogenesis of an epithelial tube |
GO_0005977 | Biological process | glycogen metabolic process |
GO_0010288 | Biological process | response to lead ion |
GO_0051301 | Biological process | cell division |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0005981 | Biological process | regulation of glycogen catabolic process |
GO_0006446 | Biological process | regulation of translational initiation |
GO_0016311 | Biological process | dephosphorylation |
GO_0043247 | Biological process | telomere maintenance in response to DNA damage |
GO_0043153 | Biological process | entrainment of circadian clock by photoperiod |
GO_2001241 | Biological process | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0060828 | Biological process | regulation of canonical Wnt signaling pathway |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005730 | Cellular component | nucleolus |
GO_0098793 | Cellular component | presynapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0043197 | Cellular component | dendritic spine |
GO_0042587 | Cellular component | glycogen granule |
GO_0043204 | Cellular component | perikaryon |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005912 | Cellular component | adherens junction |
GO_0005737 | Cellular component | cytoplasm |
GO_0072357 | Cellular component | PTW/PP1 phosphatase complex |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005634 | Cellular component | nucleus |
GO_0004721 | Molecular function | phosphoprotein phosphatase activity |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0043021 | Molecular function | ribonucleoprotein complex binding |
GO_0008157 | Molecular function | protein phosphatase 1 binding |
GO_0098641 | Molecular function | cadherin binding involved in cell-cell adhesion |
GO_0046872 | Molecular function | metal ion binding |
GO_0004722 | Molecular function | protein serine/threonine phosphatase activity |
GO_0016791 | Molecular function | phosphatase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PPP1CA |
Protein name | Serine/threonine-protein phosphatase (EC 3.1.3.16) Protein phosphatase 1, catalytic subunit, alpha Protein phosphatase 1, catalytic subunit, alpha isoform protein-serine/threonine phosphatase (EC 3.1.3.16) Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PP-1A) (EC 3.1.3.16) |
Synonyms | PPP1A |
Description | FUNCTION: Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets. Protein phosphatase 1 (PP1) is essential for cell division, and participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Involved in regulation of ionic conductances and long-term synaptic plasticity. May play an important role in dephosphorylating substrates such as the postsynaptic density-associated Ca(2+)/calmodulin dependent protein kinase II. Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. Regulates NEK2 function in terms of kinase activity and centrosome number and splitting, both in the presence and absence of radiation-induced DNA damage. Regulator of neural tube and optic fissure closure, and enteric neural crest cell (ENCCs) migration during development. In balance with CSNK1D and CSNK1E, determines the circadian period length, through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. May dephosphorylate CSNK1D and CSNK1E. Dephosphorylates the 'Ser-418' residue of FOXP3 in regulatory T-cells (Treg) from patients with rheumatoid arthritis, thereby inactivating FOXP3 and rendering Treg cells functionally defective . Dephosphorylates CENPA . Dephosphorylates the 'Ser-139' residue of ATG16L1 causing dissociation of ATG12-ATG5-ATG16L1 complex, thereby inhibiting autophagy . .; FUNCTION: (Microbial infection) Necessary for alphaviruses replication. . |
Accessions | C0STL0 P62136 ENST00000679175.1 C4TNW5 C4TNW6 ENST00000376745.9 [P62136-1] ENST00000312989.11 [P62136-2] E9PMD7 ENST00000527663.6 A0A7I2V4F7 ENST00000358239.8 [P62136-3] |